Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial

Andrew W. Creamer, Shaney L. Barratt
Breathe 2019 15: 140-143; DOI: 10.1183/20734735.0002-2019

Article Information

vol. 15 no. 2 140-143
DOI 
https://doi.org/10.1183/20734735.0002-2019
Published By 
European Respiratory Society
Print ISSN 
1810-6838
Online ISSN 
2073-4735
History 
  • Published online June 1, 2019.
Copyright & Usage 
Copyright ©ERS 2019 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Andrew W. Creamer1⇑ and
  2. Shaney L. Barratt2
  1. 1Respiratory Medicine, North Bristol NHS Trust, Westbury on Trym, UK
  2. 2Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Westbury on Trym, UK
  1. E-mail: andrewcreamer{at}doctors.org.uk
View Full Text

Article usage

Article usage: May 2019 to February 2023

AbstractFullPdf
May 2019011
Jun 201919600168
Jul 201948533
Aug 201914418
Sep 201903922
Oct 201964517
Nov 201926120
Dec 20191255
Jan 202014715
Feb 202023613
Mar 202027012
Apr 20201368
May 202034511
Jun 202024213
Jul 20202198
Aug 20203384
Sep 20205568
Oct 20202338
Nov 20201402
Dec 202023010
Jan 202113410
Feb 20214469
Mar 20211426
Apr 20211367
May 202134510
Jun 20211422
Jul 202113216
Aug 20210555
Sep 20216648
Oct 202106226
Nov 202115516
Dec 20210211
Jan 202203825
Feb 20222148
Mar 20221244
Apr 20220174
May 202222412
Jun 20220146
Jul 20221186
Aug 20220127
Sep 202222112
Oct 20220179
Nov 20220246
Dec 20221914
Jan 20231208
Feb 20231206

Altmetrics

Back to top
Email
Print
Citation Tools

Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial
Andrew W. Creamer, Shaney L. Barratt
Breathe Jun 2019, 15 (2) 140-143; DOI: 10.1183/20734735.0002-2019
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

Subjects